HUMA

Humacyte, Inc. Common Stock

$1.45 +11.54%

Recent alerts on HUMA

All signals →

Insider trade Purchase by Sebelius Kathleen

Insider trade Purchase by Constantino Michael T.

Insider trade Sale by Sander Dale A. (CFO and Chief Corp. Dev. Off)

Insider trade Sale by Parikh Shamik J (Chief Medical Officer)

News Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback

News Humacyte Posts Q2 Revenue Miss

News US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone'

News Humacyte, Inc. (HUMA) Declines More Than Market: Some Information for Investors

News Wall Street Breakfast: The Week Ahead

News Humacyte regains ex-U.S. rights to Symvess from Fresenius Medical Care

SEC filing HUMA Expands Global Symvess Rights via Fresenius Amendment, Ex-U.S. Royalties, Saudi/Israel Expansion

SEC filing HUMA Prices $20M Offering, Funds Symvess Launch, Pipeline Expansion

SEC filing HUMA Announces FDA Approval of Symvess BLA, Launches U.S. Market, 40K Annual Capacity

News Humacyte jumps as U.S. legislation backs bioengineered vessels

News Dollar Trade Has Further to Run, Nomura's Bunning Says

Get push alerts for HUMA

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS